Memorial Sloan-Kettering
The talks focused on studies stemming from the Cancer Moonshot initiative's Human Tumor Atlas Network project, which is readying its first data release.
Genome Sequencing Identifies Myeloma Precursor Disease With High Progression Risk
Investigators flagged a set of myeloma-defining genomic events that marked precursor conditions that were prone to morph into multiple myeloma.
A TMB-high cutoff of 10 mutations per megabase doesn't predict immunotherapy responses universally well across cancer types, according to a paper published in JAMA Oncology.
MSK Team Explores Clinical Utility of Germline Testing for Pediatric Cancer Patients
The researchers found that 18 percent of pediatric cancer patients tested with MSK-IMPACT harbored one or more inherited risk mutation.
Increased incidental detection of clonal hematopoiesis and new considerations for mutations in myelodysplastic precursors herald improved precision medicine strategies.